ADELA
Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.
ADELA
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2020-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.adelabio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
108 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Base Molecular Resonance Technologies
Base Molecular Resonance Technologies detects every element on the periodic table and detects cancer.
Intellihealth
Intellihealth is changing the perception of obesity and redefining how it is treated.
Next Medical
Next Medical is a developer and operator of a patient-centric telemedicine platform intended to fast-track medical testing.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Sapphiros
Sapphiros invest in and provide operational support to a select cohort of innovative diagnostics companies.
Thrive Earlier Detection
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Trice Medical
Trice Medical specializes in providing solutions for orthopedic diagnostics.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series A - Adela
LabCorp
LabCorp investment in Series A - Adela
OrbiMed
OrbiMed investment in Series A - Adela
Decheng Capital
Decheng Capital investment in Series A - Adela
RA Capital Management
RA Capital Management investment in Series A - Adela
Deerfield Management
Deerfield Management investment in Series A - Adela
Deerfield
Deerfield investment in Series A - Adela
RA Capital Management
RA Capital Management investment in Series A - Adela
F-Prime Capital
F-Prime Capital investment in Series A - Adela
OrbiMed
OrbiMed investment in Series A - Adela
Key Employee Changes
| Date | New article |
|---|---|
| 2023-12-14 | Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO |
Official Site Inspections
http://www.adelabio.com Semrush global rank: 9.02 M Semrush visits lastest month: 445
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Adela"
ADELA | A breakthrough approach to early detection
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need broadly across multiple cancers …See details»
AcelaBio – Histopathology and Precision Medicine Services for …
AcelaBio is a state-of-the-art contract research organization delivering end-to-end histopathology and precision medicine laboratory services for pharmaceutical, biotech, and academic …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Serving most recently as interim CEO to Adela, she has already demonstrated her ability to engage and lead this mission-driven organization in delivering results.” Ms. Alderson, a …See details»
Adela - Crunchbase Company Profile & Funding
Organization. Adela . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Adela creates develops technologies centered …See details»
Adela, Inc. - LinkedIn
Adela, Inc. | 4,122 followers on LinkedIn. Imagine a world in which a single blood draw can be used to detect and enable early treatment of many different diseases | Adela’s mission is to ...See details»
Adela Company Profile - Office Locations, Competitors, Revenue
Adela $60 m in total funding,. See insights on Adela including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Toronto biotech startup Adela raises $60-million from top U.S ...
Jun 23, 2021 A leading biotechnology startup from Toronto's University Health Network (UHN) has raised US$60-million form some of the biggest U.S. investors in the sector to help develop …See details»
Adela Announces Executive and Board of Directors Appointments …
May 23, 2022 Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments to the Executive Team and …See details»
Adela - BioCT
Email: [email protected]. General Information: Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. The DNA …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Ms. Alderson, a seasoned leader and founder dedicated to improving patient care and advancing the adoption of precision medicine, has served on Adela's Board of Directors since early 2022, …See details»
Adela Announces Executive and Board of Directors Appointments …
May 23, 2022 /PRNewswire/ -- Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments...See details»
Adela Debuts with $60M in Series A Financing and a Breakthrough ...
Jun 23, 2021 Find more information at adelabio.com. Contact Adela: Kelli Kampanis (Media) [email protected]. Article content. We apologize, but this video has failed to load. …See details»
Adela Initiates Key Study for Cancer Early Detection Program
May 25, 2022 The CAMPERR Study is currently enrolling participants at City of Hope, a cancer research and treatment organization, and Cleveland Clinic. ... [email protected]. RECENT …See details»
Adela Debuts with $60M in Series A Financing and a Breakthrough ...
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) -- Adela (formerly DNAMx) has launched with $60 million USD in Series A financing to enable the detection of cancer and other high …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Dec 14, 2023 Ms. Alderson is a seasoned healthcare CEO who brings over 20 years of experience building early-stage companies at the intersection of technology and healthcareSee details»
Adela Initiates Key Study for Cancer Early Detection Program
May 25, 2022 The CAMPERR Study is currently enrolling participants at City of Hope, a cancer research and treatment organization, and Cleveland Clinic. Additional institutions will be added.See details»
Adela Debuts with $60M in Series A Financing and a Breakthrough ...
Jun 23, 2021 The technology is initially being developed for use across the cancer continuum for detection, diagnosis, and management, and in the future will be applied to other conditions …See details»
ADELA | Adela Announces $48 Million in Financing and Leadership ...
Sep 25, 2023 Investors include F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, Labcorp and RA Capital Management. Proceeds from this financing will be used to …See details»
Adela Debuts with $60M in Series A Financing and a
Jun 23, 2021 Find more information at adelabio.com. Tags #methylome #methylationenrichment #cancerdetection #methylatedDNA. Contact Data. ContactSee details»